噬菌体市场规模、份额和成长分析（按产品类型、给药途径、分销管道、应用、最终用途行业和地区）- 2025-2032 年行业预测

2023 年全球噬菌体市场规模为 4,960 万美元，预计将从 2024 年的 5,243 万美元成长到 2032 年的 8,169 万美元，预测期内（2025-2032 年）的复合年增长率为 5.7%。

全球噬菌体市场正在成为对抗抗生素抗药性和细菌感染的关键解决方案。噬菌体是一种特异性针对细菌的病毒，是传统抗生素的有希望的替代品。人们对抗生素抗药性细菌这一全球健康威胁的担忧日益加剧，刺激了市场的成长。噬菌体因其高度特异性、与细菌共同进化的能力以及对有益微生物群的干扰最小而受到广泛欢迎。噬菌体疗法在临床前和临床试验中都表现出了良好的效果，并且某些地区的监管核准增加了其市场可行性。随着製药公司和研究机构之间的合作加强，市场将会扩大，透过提供个人化的治疗方案和降低抗药性风险，噬菌体将成为抗生素领域的关键参与者。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

噬菌体市场规模（依产品类型和复合年增长率） (2025-2032)

• 市场概况
• 噬菌体益生菌
• 噬菌体治疗公司

噬菌体市场规模（依给药途径及复合年增长率） (2025-2032)

• 市场概况
• 口服
• 外用药物
• 其他的

噬菌体市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 零售药局
• 医院药房
• 网路药局

噬菌体市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 胃肠病学
• 治疗呼吸道感染疾病
• 治疗皮肤感染疾病
• 伤口预防
• 泌尿系统感染疾病的治疗

噬菌体市场规模（以最终用途产业和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 专科门诊
• 居家护理
• 其他的

噬菌体市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Intralytix（United States）
• Proteon Pharmaceuticals（Poland）
• Phagelux（China）
• Micreos（Netherlands）
• Eliava BioPreparations（Georgia）
• Locus Biosciences（United States）
• Pherecydes Pharma（France）
• APS Biocontrol Ltd.（United Kingdom）
• Qingdao Phagepharm Biotech（China）
• Fixed-Phage Limited（United Kingdom）
• Zeptometrix（United States）
• Phage International, Inc.（United States）
• Micromir（Russia）
• Armata Pharmaceuticals, Inc.（United States）
• Nextbiotics（United States）
• InnoPhage, Ltd（Portugal）
• TechnoPhage（Portugal）
• Eligo Bioscience SA（France）
• NPO Microgen（Russia）
• Pharmex Group, LLC（Russia）

结论和建议

Global Bacteriophage Market size was valued at USD 49.6 million in 2023 and is poised to grow from USD 52.43 million in 2024 to USD 81.69 million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global bacteriophage market is emerging as a vital solution to antibiotic resistance and bacterial infections. Bacteriophages, which are viruses that specifically target bacteria, present a promising alternative to conventional antibiotics. The market's growth is fueled by increasing concerns over antibiotic-resistant bacteria, which are a significant global health threat. With their high specificity, capacity to evolve alongside bacteria, and minimal disruption to beneficial microbiota, bacteriophages are gaining traction. Phage therapy has shown encouraging results in both preclinical and clinical trials, and regulatory approvals in certain regions are enhancing market viability. As collaboration between pharmaceutical companies and research institutions intensifies, the market is poised for expansion, providing personalized treatment options and reducing resistance risks, thereby positioning bacteriophages as critical players in the antimicrobial landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacteriophage market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacteriophage Market Segments Analysis

Global Bacteriophage Market is segmented by Product Type, Route of Administration, Distribution Channel, Application, End-use Industry and region. Based on Product Type, the market is segmented into Phage Probiotics and Phage Therapeutics. Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroenterology, Respiratory Infections Treatment, Skin Infection Treatment, Wound Prophylaxis and Urological Infection Treatment. Based on End-use Industry, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacteriophage Market

The rising incidence of antibiotic-resistant bacterial infections is significantly boosting the demand for alternative treatment solutions. Bacteriophages, which are viruses specifically designed to target and eliminate certain bacteria, present a compelling option for tackling antibiotic-resistant strains and superbugs. With traditional antibiotics becoming less effective, the global bacteriophage market is experiencing growth driven by the necessity for novel and tailored therapeutic strategies. This shift towards bacteriophage therapy highlights the urgent need for innovative solutions in the face of mounting challenges posed by resistant bacteria, ultimately shaping the future of infectious disease management and treatment modalities.

Restraints in the Global Bacteriophage Market

The global bacteriophage market faces significant restraints primarily due to the regulatory challenges associated with the use of live viruses in bacteriophage therapy. These challenges stem from safety concerns that necessitate extensive testing and approval processes to ascertain the safety and efficacy of these products, often leading to time-consuming and expensive procedures. Additionally, the presence of regulatory uncertainties and discrepancies across various regions can further impede the growth and expansion of the market. As a result, these factors may limit the accessibility and acceptance of bacteriophage therapies, ultimately affecting market potential and development.

Market Trends of the Global Bacteriophage Market

The Global Bacteriophage market is witnessing a significant upward trend, propelled by a surging interest in phage therapy amid the escalating crisis of antibiotic resistance. As traditional antibiotics become less effective against harmful bacterial pathogens, the medical community is increasingly turning to bacteriophages, which specifically target and eliminate resistant bacteria. Advances in phage biology, innovative isolation techniques, and successful clinical case studies are enhancing the viability of phage therapy as a therapeutic alternative. This paradigm shift in treating bacterial infections suggests a robust future for the bacteriophage market, estimated to grow exponentially as it addresses unmet medical needs worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Bacteriophage Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Phage Probiotics
• Phage Therapeutics

Global Bacteriophage Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical
• Others

Global Bacteriophage Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Bacteriophage Market Size by Application & CAGR (2025-2032)

• Market Overview
• Gastroenterology
• Respiratory Infections Treatment
• Skin Infection Treatment
• Wound Prophylaxis
• Urological Infection Treatment

Global Bacteriophage Market Size by End-use Industry & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare
• Others

Global Bacteriophage Market Size & CAGR (2025-2032)

• North America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • US
  • Canada
• Europe (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Intralytix (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteon Pharmaceuticals (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phagelux (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micreos (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eliava BioPreparations (Georgia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Locus Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pherecydes Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APS Biocontrol Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qingdao Phagepharm Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fixed-Phage Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeptometrix (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phage International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micromir (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Armata Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nextbiotics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnoPhage, Ltd (Portugal)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TechnoPhage (Portugal)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eligo Bioscience SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NPO Microgen (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmex Group, LLC (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations